ADIPOQ and metabolic dysfunction-associated steatotic liver disease: ADIPOQ, associated with ENSG00000226482, is involved in the PPAR signaling pathway (PathwayID: hsa03320), type II diabetes mellitus (PathwayID: hsa04930), the adipocytokine signaling pathway (PathwayID: hsa04920), the longevity regulating pathway—mammal, the AMPK signaling pathway, and non-alcoholic fatty liver disease (NAFLD) (PathwayID: hsa04932).